Alexandria RE elects Claire Aldridge, PhD to board, effective March 14, 2025

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Board size increased from 8 to 9; Aldridge serves until 2025 annual meeting.
She was chief strategy officer at Form Bio, a Colossal Biosciences spinout, with 25+ years in life science.
Upon election, receives 1,000 restricted shares vesting on second anniversary.
Appointed to Life Science Committee; determined independent under NYSE and SEC rules.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Claire Aldridge, Ph.D.

director

ARE · ALEXANDRIA REAL ESTATE EQUITIES, INC.

Effective: 2025-03-14
Filed: March 6, 2025, 6:59 PM ET

elected Claire Aldridge, Ph.D., as a director of the Company, effective March 14, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Claire Aldridge, Ph.D. was elected as director at ALEXANDRIA REAL ESTATE EQUITIES, INC..

Action: elected
Role: director

Exact text from the filing

elected Claire Aldridge, Ph.D., as a director of the Company, effective March 14, 2025

View on SEC.gov

ALEXANDRIA REAL ESTATE EQUITIES, INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-021383

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.